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Methods for labeling the glutamate channel blocking agent MK-801 with iodine-125 (‘*‘I) and fluorine-18 
(‘*F) are described. Radioiodine was incorporated in the l- or 3-positions of the aromatic ring of 
(+)MK-801 by solid-state halogen exchange techniques. Attachment of the [‘sF]fluoromethyl group to 
the bridgehead methyl position was achieved by reaction of [“Flfluoride with the triflamide alcohol 8 or 
the novel cyclic sulfamate 9 recently reported by Merck chemists. Radiochemical yields of (+)13-[“F]- 
fluoromethyl-MK-801 were >72%, EOB; radiochemical purity >99%. In competitive binding studies 
using rat brain homogenates, (f)3-bromo-MK-801 showed greater affinity than (+)MK-801 for the 
glutamate-linked channel. The experimental log P (2.1 k 0.1) of MK-801 is optimal for transit of the 
blood-brain barrier. These preliminary findings support further testing of 3-[‘231]iodo-MK-801 and 
( &)13-[‘8F]fluoromethyl-MK-801 as possible agents for in oivo mapping of the glutamate receptor 
complex. 
Introduction 
The amino acid glutamate is a major excitatory 
neurotransmitter in mammalian brain (Watkins and 
Evans, 1981). MK-801, a potent anticonvulsant and 
neuroprotective agent, has been shown to non- 
competitively bind to a subset of glutamate binding 
sites termed the N-methyl-n-aspartate (NMDA) re- 
ceptor (Wong et al., 1986, 1988). Activation of the 
6Hs 
MK-801 
NMDA receptor opens a channel that permits Ca*+ 
and other cations to pass into the neuron. It is to 
this channel, when in the open state, that MK-801 
is thought to bind. The psychotropic drug phen- 
cyclidine (PCP) has also been shown to bind to this 
NMDA-operated open channel (Honey et al., 1985). 
However, MK-801 binds with greater affinity and 
*Correspondence should be addressed to: Donald M. 
Wieland, Ph.D., University of Michigan, Cyclotron/ 
PET Facility, 3480 Kresge III Building, Ann Arbor, 
MI 48109-0522, U.S.A. 
specificity; it has a KD of 6.3 nM for the NMDA 
receptor channel and little affinity for the sigma 
opiate receptor (Wong et al., 1988). 
The NMDA receptor complex may play a pivotal 
role in many brain diseases. Excessive stimulation of 
NMDA receptors has been implicated in neuro- 
degenerative disorders such as Alzheimer’s disease 
(Greenamyre et al., 1985; Deutsch and Morisha, 
1988) psychotic processes (Olney, 1987) epilepsy 
(Meldrum, 1987) and ischemia-induced neuronal de- 
generation. Initial studies in animal models of both 
global and focal ischemia have shown that MK-801 
protects against glutamate-induced neuronal damage 
when given before or shortly after the ischemic insult 
(Kemp et al., 1987). 
The goal of this preliminary work was to explore 
strategies for synthesizing radiolabeled derivatives 
of MK-801 for in vivo mapping of the NMDA- 
linked cation channel. Both radioiodinated and 
” C/‘*F-tracers have been pursued in hopes of devel- 
oping agents for evaluation by SPECT and PET, 
respectively. Synthetic routes to MK-801 and its 
analogs are described only in the patent literature; 
structure-activity relationship (SAR) studies have 
not been published. This report describes the syn- 
thesis of two isomeric ‘25 I-labeled derivatives of 
(+)MK-801 and a [i8F]fluoromethyl derivative. 
Results of K, value determinations for these three 
derivatives suggest that two of the tracers merit in 
vivo evaluation as NMDA receptor channel markers. 
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Experimental 
Materials and methods 
(-t)MK-801 [( $)-5-methyl-IO,1 I-dihydro-5H-di- 
benzo[a,d]cyclohepten-5, IO-imine] and its 13-hydroxy- 
methyl derivative 1 were synthesized according to 
patent procedures (Anderson et al., 1983; Bender et 
al., 1984). The cyclic sulfamate 9 and its sulfonamide 
precursor 8 were obtained by a slight modification 
of the method of Lyle et al., 1987. Racemic 3-bromo- 
MK-801 was a generous gift of Merck Sharp & 
Dohme Research Laboratories, West Point, Penn. 
Na[‘251] (no carrier added) and [3H]TCP were pur- 
chased from Dupont/NEN. 
Thin-layer chromatography (TLC) was performed 
on Whatman K6F silica gel glass-backed plates 
(250 pm), E. Merck neutral alumina plastic-backed 
plates (0.2pm), or Whatman KCl8F reverse phase 
glass-backed plates (200 pm). Sep-PaksTM were from 
Waters Associates. Flash chromatography was per- 
formed by the procedure of Still et al. (1978). High- 
pressure liquid chromatography (HPLC) was carried 
out on either a Waters system consisting of a Model 
680 gradient controller, two Model 510 pumps, and 
Model U6K injector, or on a combined system 
composed of a Beckman Model I 10B pump and a 
Rheodyne Model 7125 injection valve fitted with a 
500 p L sample loop. Detection was performed with 
either a Kratos Model SF773 u.v./vis. detector at 
230 nm or an ISCO Model UA-5 U.V. detector with a 
280 nm filter, and a Beckman Model 170 or a Radio- 
matic Model DR/IC Flo-One radioisotope detector. 
Melting points were determined on a Fisher-Johns 
melting point apparatus and are uncorrected. Radio- 
TLC chromatograms were scanned on a Berthold 
Linear Analyzer LB 282. Infrared spectra were 
recorded on either a Perkin-Elmer 727B or a Nicolet 
5X FT-i.r. spectrometer. ‘H-NMR spectra were ob- 
tained on a Varian EM-360 (60 MHz), a Bruker 
AM-300 (300 MHz) or a Bruker WM-360 (360 MHz) 
instrument. 13C-NMR spectra were recorded on a 
Bruker WM-360 instrument at 90.5 MHz and are 
completely decoupled. Mass spectra were obtained 
on a Finnigan 4021 GCMS/DS (low resolution) or a 
VG70-250-S (high resolution) instrument. GC/MS 
analyses were done on a Hewlett-Packard 5890 gas 
chromatograph equipped with a mass selective de- 
tector with a direct interface. Elemental analyses were 
performed by Spang Microanalytical Laboratories, 
Eagle Harbor, Mich. 
In vitro binding assa) 
The affinity of the compounds for the NMDA- 
linked receptor channel was determined using the 
procedure of Vignon et al., (1983, 1986) with modifi- 
cations. Male Sprague-Dawley rats (250 g) were 
killed by decapitation. The cerebral cortices were 
dissected and homogenized for 15 s in 50 mL of 
Tris acetate buffer (50 mM, pH 7.2 at 4°C) using a 
Brinkmann tissue homogenizer. The crude mem- 
brane receptor preparation was kept in an ice-cold 
bath until measurement of [3H]TCP binding. This 
measurement was performed by incubating 1 mL 
(triplicate aliquots) of the crude membrane sus- 
pension (ca 45 mg of protein) with 20 PL of either a 
solution of the test compound in methanol or the 
buffer alone (total binding), and 1 mL of 6 nM 
[‘H]TCP. Unlabeled TCP, 20 PL (20 PM final 
concentration) was used for determination of non- 
specific binding. 
The binding reaction was initiated by adding 
[‘H]TCP to the membrane suspensions and allowing 
the tubes to stand at room temperature for 1 h. 
Incubation was terminated by rapid filtration 
through Whatman GF/B filters presoaked with 0.5% 
aqueous polyethylenimine. The filters were rapidly 
washed 3 times with 5 mL cold buffer and then 
suspended in 5 mL of Hydrofluor and allowed to 
stand at room temperature for 1.5 h before liquid 
scintillation counting. Protein concentrations were 
determined according to the method of Bradford 
(1976). 
We previously reported saturation curves for 
[‘HITCP binding to rat brain homogenates (Albin et 
al., 1988). Scatchard analysis indicated a single class 
of binding sites with a mean K,, of 45 nM and a 
mean B,,, of 773 fmol/mg protein. In this study, 
the concentrations of unlabeled MK-801 derivatives 
displacing 50% of specific [3H]TCP binding (IC,,) 
were determined. The binding affinity constants 
(K,) were then calculated using the equation: 
K, = I&,/( 1 + [L]/K,); the concentration of [3H]TCP 
(IL]) utilized in the inhibition studies was 6 nM. 
Log P determination 
The log P of MK-801 was determined according to 
the method of Frey et al. (1983), using unlabeled 
compound (free base) and octanol/phosphate 
buffered saline (PBS), pH 7.4. The amount of MK- 
801 in the PBS phase was determined spectrophoto- 
metrically by extraction with ethyl ether, solvent 
removal, redissolving in absolute ethanol and 
comparison with a standard curve of free base 
MK-801 obtained in ethanol at 276.5 nm. Three 
determinations were made. 
Preparation of (?)I-iodo-MK-801 
To a solution of (k)MK-801 (315 mg, 1.40 mmol) 
in 85% H,SO, (17 mL) were added silver sulfate 
(222 mg, 0.21 mmol) and iodine (181 mg, 0.71 mmol). 
The resulting mixture was stirred at room tem- 
perature for 7 h. It was then cooled to 0°C and 
carefully neutralized with 10% NaOH. The neutral 
solution was extracted with CH,Cl, (3 x 10 mL) and 
the combined extracts were dried over MgSO, and 
concentrated in uacwo. GC/MS analysis of this crude 
material showed one major (tR = 9.59 min, ca 79% 
chemical yield) and two minor monoiodinated 
products. Flash chromatography using hexane:ethyl 
acetate 1: 1 provided a heart fraction (25 mg) of 
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the major isomer as a clear oil; ‘H-NMR (CDCI,): 
6 = 1.92 (s, 3H, CH,); 2.46-2.56 (m, lH, NH); 2.59 
(d, lH, J = 17.2Hz, H,,,); 3.23 (dd, lH, J = 17.2, 
5.7 Hz, H,,,); 4.73 (d, lH, J = 5.7 Hz, H,& 7.62 (dd, 
IH, J = 7.9, 1.1 Hz, HZ); 6.82 (t, lH, J = 7.8 Hz, H,); 
7.05-7.07 (m, H,); 7.12 (td, lH, J = 7.3, 1.5 Hz, H,); 
7.15 (td, lH, J = 7.3, 1.6 Hz, H,); 7.27-7.33 (m, 2H, 
H, and H,); ‘-‘C-NMR (CDCI,): 6 = 20.08, (CH,); 
41.67 (C,,); 58.63 (C,,); 64.19 (C,); 103.83 (C,); 
118.64, 121.53, 126.95, 127.05, 127.57, 137.88, 135.21, 
144.49, 146.60, 151.27; mass spectrum, m/e 347(M+). 
Treatment of this oil with HCl provided the corre- 
sponding hydrochloride salt; m.p. 205-207°C. Anal. 
Calc. for C,,H,,IN.HCI: C, 50.09; H, 3.94; N, 3.65. 
Found: C, 49.69; H, 3.69; N, 3.46. 
Synthesis of (_+,)I - [‘2sl]iodo-MK-801 
Radioiodide labeling was achieved by an ammo- 
nium sulfate catalysed solid-phase exchange tech- 
nique described previously (Mangner et al., 1982; 
Otto et al., 1986). Exchanges were conducted in 
3 mL septum sealed multi-dose vials vented with a 
disposable IOcm’ plastic syringe which served as 
the distillate condenser. Charcoal and aqueous 
sodium thiosulfate traps were connected in series 
with the condenser to trap any volatile radioiodine 
that was released during the heating process. In 
a typical procedure, a solution containing 6.3 mg 
of (NH,),SO,, 25 pg of (&-)I-iodo-MK-801, and 
6.5 mCi of Na12”I in 300 PL of ethanol/water (1 : 1) 
was heated to dryness in an oil bath at 180°C. Air 
(10 mL) was slowly injected over a I-min period, and 
the reaction mixture was maintained at 180-185°C 
for an additional 30min. After cooling to room 
temperature, the reaction mixture was extracted 
with acetone (5OOpL) and analyzed by radio-TLC 
(silica:Et,O:CH,CN:NH,OH, 70:30:5; R,=0.28; 
radiochemical yield 83%). Evaporation of the ace- 
tone left a residue which was extracted with CH,CI, 
(2 x 1 .O mL) and transferred to a silica Sep-Pak. The 
Sep-Pak was successively washed with 4 mL each of 
hexane, hexane/EtOAc (9: l), hexane/EtOAc (3: I), 
and hexane/EtOAc (1: 1) to remove less polar im- 
purities. Subsequent elution with 4mL of EtOAc 
yielded 2.8 mCi of desired product; radiochemical 
purity was >99% by radio-TLC and isolated radio- 
chemical yield was 47%. The specific activity was 
> 60 Ci/mmol. 
The radioligand was stored in absolute ethanol 
(5.8mCi/mL) at -20°C in the dark until needed. 
Under these conditions, no radiolytic decomposition 
was observed up to 46 days after synthesis. Just prior 
to biological testing the solvent was evaporated and 
the compound was formulated in ethanol/5 mM 
sodium acetate buffer, pH 4.5, (15 : 85). 
Synthesis of (_+)3-[‘251jiodo -MK-801 
7.27 mCi of Na’251 were combined and heated to 
dryness at 230°C in an oil bath. Air was then slowly 
passed through the reaction vial for 1 min. The dry 
mixture was maintained at 230°C for an additional 
30min, cooled to room temperature, dissolved in 
acetone (200 pL) and subjected to radio-TLC anal- 
ysis (silica, CH,CN: Et,O:NH,OH, 3: 7:0.1). Fol- 
lowing removal of the acetone by means of a gentle 
stream of argon, the dry reaction mixture was dis- 
solved in CH,Cl, (3 x 0.5 mL) and transferred to a 
silica Sep-PakTM. Elution with hexanes (10 mL) 
followed by EtOAc (5 mL) removed the less 
polar impurities. Further elution with CH,CN 
(10 mL) afforded 1.67 mCi of ( f )3-[‘25 Iliodo- 
MK-801 in >95% radiochemical purity as deter- 
mined by radio-TLC. The radiochemical yield was 
23%. HPLC was used for the preparative separation 
of ( +)3-[‘251]iodo-MK-801 from the precursor 
(f)3-bromo-MK-801. The separation was made 
on an Ultremex IPTM column with guard column 
[0.46 x (25 + 5) cm, 5-pm particle, C-l 8; Phenom- 
enex, Ranch0 Pales Verdes, Calif.] with a mobile 
phase consisting of a mixture of 50mM aqueous 
ammonium formate/CH,CN (1 : 1) and a flow rate of 
1.2 mL min’. Under these conditions, the retention 
times for 3-bromo-MK-801 and 3-[‘251]iodo-MK-801 
were 11.6 and 25.1 min, respectively. During elution 
of the radioactive peak, I-min fractions were 
collected and the heart fractions were pooled. 
The effective specific activity and radiochemical 
purity were assayed by radio-HPLC. The separation 
was made on an ultrasphere IPTM column with 
guard column [0.46 x (25 + 4.5) cm, 5-pm particle 
size, C-18; Beckman Instruments] with CH,CN: 
0.2 M ammonium formate (1: 1) as eluant and a flow 
rate of 1.5 mL min-‘. For this system, the retention 
times of MK-801, 3-bromo-MK-801, and 3-[‘251]- 
iodo-MK-801 were 5.0, 8.8, and 10.9min, respect- 
ively. To calculate the effective specific activity, the 
concentrations of both residual 3-bromo-MK-801 
and3-[1251]iodo-MK-801 weredetermined.Theconcen- 
tration of residual 3-bromo-MK-801 was determined 
by comparing the 3-bromo-MK-801 peak area with 
that of external standards, while that of 3-[‘251]iodo- 
MK-801 was calculated by assaying the amount of 
lz51 in an aliquot of the preparation in an autogamma 
counter (Model 1195; TM Analytic, Elk Grove 
Village, Ill.) and correcting for counting efficiency. 
Prior to biological evaluation, the volume of the 
pooled heart fractions was reduced by evaporation 
under an argon stream at 40°C. The remaining 
aqueous layer was saturated with NaCI, and the 
radioligand was extracted into hexane. After 
evaporating the hexane under argon, the radioligand 
was formulated in ethyl alcohol/phosphate buffered 
saline, pH 6.5, (15 : 85). 
In a typical procedure, a solution of (NH,),SO, Preparation of tetrabutylammonium [“F]Jluoride 
(5.0 mg in 15 PL of deionized H,O), (+)3-bromo- [‘8F]Fluoride ion was produced by proton 
MK-801 .HCl (1OOpg in 1OOpL of ethanol) and irradiation of [‘*O]water (86% isotopic enrichment, 
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Mound Laboratories) in an all-silver cyclotron target. 
Aliquots (I-50 mCi, 10-200 pL) were combined with 
2 pmol of tetrabutylammonium hydroxide and 
evaporated in a VacutainerTM essentially as per pub- 
lished methods (Brodack et al., 1986). The tetrabutyl- 
ammonium [I8 Flfluoride was then resolubilized in 
100-200 p L of dry acetonitrile and transferred to a 
suitable reaction vessel. Resolubihzation efficiencies 
were 80--90%. 
Synthesis of (_t)13-[‘8F]~uoromethyl-MK-801 
To a solution of tetrabutylammonium [“Flfluoride 
in acetonitrile (lo&200 p L) was added a solution of 
1 mg of either triflamide alcohol 8 or cyclic sulfamate 
9 in 50 PL acetonitrile, and the solution heated 
(IOOC, closed vessel) for 5-15 min. The vessel was 
cooled slightly, then 200 p L of 6N HCl added and the 
aqueous mixture heated (lOO”C, closed vessel) for an 
additional 5-l 5 min. After brief cooling, the aqueous 
mixture was added dropwise to 10mL of saturated 
aqueous sodium bicarbonate. This aqueous mixture 
was then passed through a C-18 Sep-Pak, which was 
further washed with 5 mL of water. The product was 
eluted with 4mL of chloroform and the organic 
solution dried over anhydrous sodium sulfate. 
In experiments performed simultaneously, radio- 
chemical yields of “F-3 from triflamide alcohol 8 
or cyclic sulfamate 9 were essentially identical, 72 
and 74% EOB, respectively. Total synthesis time 
was 50min. Radiochemical purity was >99% as 
determined on three TLC systems: silica, 98/2 ethyl 
acetate/NH,OH (R, = 0.42), MK-801 (R, = 0.28), 
chloromethyl-MK-801 (R, = 0.51), hydroxymethyl- 
MK-801 (RI- 0.05); alumina, 95/5 ethyl ether/ 
ethanol, R,= 0.82; C,, reverse phase, 2/l ethanol/ 
water, R, = 0.25. Radio-HPLC analysis of the prod- 
uct, with the separation performed on Ultrasphere 
IPTM column with guard column [0.46 x 
(25 + 4.5)cm, 5-pm particle size, C-18; Beckman 
Instruments], CH, CN : 0.2 M ammonium formate 
(2:3) as eluant and a flowrate of 1.5mL min-‘, 
showed a single radioactive peak which co-eluted 
with authentic 3. Under these conditions, the 
retention times of 13-hydroxymethyl-MK-801 (l), 
MK-801, 13-[‘8F]fluoromethyl-MK-801 (3), and 
13-chloromethyl-MK-801 (10) were 6.9, 11.8, 12.9 
and 23.4 min, respectively. Analysis of chemical 
purity by TLC and HPLC showed the presence of 
traces of the alcohol 1 and chloromethyl-MK-801 
(IO). 
Synthesis of azetidine 5 
Trifluoromethane sulfonic anhydride (68 mg; 
0.24 mmol) was added dropwise to a stirred solution 
of aminoalcohol 1 (50 mg; 0.20 mmol) in anhydrous 
CH,Cl, at -78°C under dry nitrogen. The mixture 
was stirred at - 78C for an additional 45 min and 
then allowed to warm to room temperature over ca 
15 min. The reaction was quenched by addition of 
saturated aqueous NaHCO, solution (1 mL); after 
stirring for IOmin, the aqueous layer was decanted 
and back-extracted with CH,Cl, (3 x 3 mL). The 
combined organic layer and extracts were dried over 
MgSO, and concentrated in vacua. The crude product 
was purified by flash chromatography using hex- 
ane:ethyl acetate (2: 1) and then 100% ethyl acetate 
to give 27 mg (58%) of the azetidine 5 as a colorless 
oil. 
‘H-NMR(CDC1,): S 2.42 (ddd, lH, J =9.6, 6.3, 
1.5 Hz); 2.64 (d, IH, J = 16.6Hz); 2.92 [dt, IH, 
J = 7.4(d), 9.4(t), 9.4(t) Hz]; 3.12 [dt, lH, J = 9.2(d), 
6.5(t), 6.5(t) Hz]; 3.39 (d, lH, J = 5.6 Hz); 3.4c3.44 
(m, 1H); 4.42 (d, lH, J = 5.1 Hz); 6.89-6.92 (m, IH); 
7.01-7.15 (m, 3H); 7.167.24 (m, 3H); 7.29-7.32 
(m, 1H); MS (70eV): m/e 233 (M+); HRMS: m/e 
talc. for C,,H,,N: 233.1204; found: 233.1208. 
Cyclic carbamate 6 
Di-t-butyl dicarbonate (92 mg; 0.42 mmol) in 
DMF (2mL) was added to a stirred solution of 
amino alcohol 1 (100 mg; 0.40 mmol) in DMF (6 mL) 
under argon. The reaction mixture was stirred for 2 h 
at room temperature and then concentrated under 
vacuum. The residue was dissolved in CH,CI,, 
washed rapidly with 5% HCl, and dried over anhy- 
drous MgSO,. The solvent was removed under vac- 
uum to give 90 mg (64%) of carbamate as a clear oil. 
Infrared (KBr): v = 3440 (OH), 1680 (-0) cm-‘; 
‘H-NMR (60 MHz, CDCI,): 6 1.35 (s, 9H, t-Bu); 
2.4&270 (d, lH, J = 17.6Hz); 2.85-3.30 (m, 3H); 
3.4Gt.00 (m, 3H), 5.20-5.40 [d, lH(H,,), J = 5.7 Hz); 
6.8k7.20 (m, 8H). 
The above oil was dissolved in 3 mL of pyridine 
at 0°C and p-toluenesulfonyl chloride (50mg; 
0.26mmol) was added. The reaction was stirred at 
0°C for 2 h and then partitioned between water and 
CHCI,. The CHCI, layer was decanted and dried over 
anhydrous MgSO,. The solvent and residual pyridine 
were removed under vacuum to give 60 mg (83%) of 
6 as a white powder, m.p. 258-259°C. Infrared (neat): 
v = 1685.2 (C==O); ‘H-NMR (CDCI,): S 2.49-2.57 
(m, lH, J = 14.5 Hz); 2.77-2.81 (d, lH, J = 16.9 Hz); 
3.15-3.20 (m, lH, J = 14.5Hz); 3.62-3.68 (dd, 
lH, J = 16.9Hz); 4.24-4.31 (m, IH, J= 11.2Hz); 
4.354.40 (m, lH, J = 11.2Hz); 5.7G5.72 (d, lH, 
J = 5.5 Hz); 7.00-7.06 (m, 2H); 7.13-7.21 (m, 5H); 
7.347.36 (m, 1H); MS (70 eV): m/e 277 (M+); 
HRMS: m/e talc. for C,,H,,NO,: 277.323. Found: 
277.1103. Anal. talc. for C,,H,,NO,.fH,O: C, 75.50; 
H, 5.63; N, 4.89. Found: C, 75.60; H, 5.67; N, 4.79. 
Results and Discussion 
Chemistry 
The direct iodination of (k )MK-801 by the 
Derbyshire method (Derbyshire and Waters, 1950) 
provided an unexpectedly simple monoiodinated 
product pattern. It was anticipated that under condi- 
tions of stoichiometric excess of (+)MK-801 at least 
four compounds, the 2-, 3-, 7- and the 8-monoiodo 
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isomers might be formed. A major monoiodinated 
isomer was isolated from this reaction. The ‘H and 
13C NMR data, however, strongly support l-iodo- 
MK-801 as the structure of this compound. The 
aromatic region of the ‘H NMR spectrum clearly 
shows a coupling pattern suggesting substitution of 
one of the four protons ortho to the seven-membered 
ring (i.e. C,H, C,-H, C,-H or C,-H). In addition, 
there is a small upfield shift in the signals of the two 
C,,-protons relative to parent MK-801, which can be 
attributed to a shielding effect by the iodine atom in 
the C, position. The last observation is reinforced by 
the significant downfield shift (ca 7.3 ppm), relative to 
MK-801, observed for C,, in the 13C NMR spectrum 
of the iodo compound. This shift can be best attrib- 
uted to the presence of the iodine atom in the 
adjacent C, position. Finally, direct comparison of 
the ‘H and 13C NMR spectra of the monoiodo 
compound with those of 3-bromo-MK-801 also 
points to the I-iodo-MK-801 isomer as the structure 
of the product. Whether this remarkable preference 
for electrophilic attack at the l-position of MK-801 
is unique to the Derbyshire reaction remains to be 
determined. The identity of the two minor mono- 
iodinated products has not been pursued. 
The radiosynthesis of ( f)1-[‘251]iodo-MK-801 
was readily achieved by the solid-state radioiodide 
exchange method previously developed in this labora- 
tory (Mangner et al., 1983; Otto et al., 1986). Rapid 
passage of the reaction mixture through a silica 
Sep-PakTM to eliminate unreacted radioiodide and 
other radioactive inorganics was the only purification 
necessary. A radiochemical yield of 83% was ob- 
tained ata specific activity of 60 Ci/mmol; higher 
specific activities (> 100 Ci/mmol) could be achieved 
but in lower yield. 
The synthesis of (f)3-[“‘Iliodo-MK-801 was 
accomplished by interhalogen exchange with 
(f)3-bromo-MK-801. Subsequent use of HPLC was 
needed to separate most of the (i-)3-bromo-MK-801 
precursor from the desired radioactive product. This 
HPLC enrichment gave ( +)3-[‘251]iodo-MK-801 with 
an effective specific activity of > 1350 Ci/mmol. The 
synthesis of unlabeled 3-iodo-MK-801 has not been 
reported and its synthesis is presently being pursued 
in our laboratory. Thus, the evidence for the identity 
of ( +)3-[‘251]iodo-MK-801 is indirect. The fact that 
only one radioactive organic product is formed and 
that its chromatographic behavior, both TLC and 
HPLC, is very similar to 3-bromo-MK-801, argues 
strongly for interhalogen exchange rather than 
proton-halogen exchange. Further support for inter- 
halogen exchange rests on findings in our laboratory 
that ortho-chlorobenzylguanidine and PK-11195, 
an ortho -chlorophenyl derivative of isoquinohne, 
undergo exclusive interhalogen exchange with Na’*‘I 
under the solid-state conditions employed here for 
(f)3-bromo-MK-801 (Gildersleeve et al., 1988). 
The most obvious strategy for labeling MK-801 
with a positron-emitting radioisotope is to synthesize 
Table I. Structure of MK-801 derivatives 
10 II 
Compound X Y 
MK-801 -H -H 
1 -H 4?H,OH 
2 -H ZH,OTfl 
3 -H <H,F 
4 -Tf ZH,OTf 
7 -H CH,OCPh, 
8 -Tf JZH,OH 
10 -H -CH,CI 
*Tf = SO, CF, 
N-[“Clmethyl-MK-801 with a “C-labeled methyl- 
ating agent (i.e. [“Clmethyl iodide). This in fact has 
been done in our laboratory (Watkins G. L. and 
Jewett D. M., unpublished). However, as shown 
in Table 2, N-methyl-MK-801 has a 2-fold lower 
binding affinity than MK-801 in the [3H]TCP assay. 
Thus, alternatives to labeling MK-801 with carbon- 
11 have been pursued, especially those employing 
[“Flfluoride ion because of its longer half-life, ease of 
large-batch synthesis, and high specific activity. Our 
attention focused on the bridgehead methyl group as 
a possible locus for incorporating 18F. This approach 
was attractive since the synthesis of the methy- 
lenehydroxy derivative of MK-801, i.e. compound 1, 
has been described in the patent literature (Christy et 
al., 1979). It was predicted that the triflate of this 
alcohol, 2, could serve as a precursor to 18F-3, the 
1 3-[18 Flfluoromethyl derivative of MK-80 1. 
Alcohol 1 was synthesized in 7 steps from tram - 10, 
1 I-dibromodibenzosuberone. Reaction of 1 with 1.2 
equivalents of triflic anhydride failed to give the 
desired triflate 2; instead the azetidine derivative 5 
was formed, seemingly through nitrogen attack on 
the triflate formed in situ. The azetidine was also 
observed in the reaction of 1 with DAST (Mislankar 
and Wieland, unpublished observation). Reaction of 
1 with 2.5 equivalents of triflic anhydride gave the 
triflate sulfonamide 4. The imino group of 1 could be 
selectively functionalized as the t-BOC carbamate; 
however, subsequent attempts to form the triflate in 
the presence of organic bases resulted in intra- 
molecular cyclization to the carbamate 6. Reaction of 
1 with trityl chloride gave the 0-alkylated product 7; 
reaction of 7 with triflic anhydride followed by an 
aqueous acid workup yielded the triflamide 8. At this 
stage in our synthetic work, Merck scientists reported 
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Fig. 1. Synthesis of (*)13-[‘*F]tluoromethyl-MK-801 
a similar synthesis of triflamide 8 and detailed its 
anomalous reaction with Bu,N+ F- to give 3 (Lyle et 
al., 1987). The Merck scientists have demonstrated 
that this unusual fluorination reaction proceeds 
through the in situ formation of the cyclic sulfamate 
9 as shown in Fig. I. Our results reported here, in 
which either the sulfonamide alcohol 8 or the cyclic 
sulfamate 9 give high and nearly identical radio- 
chemical yields of “F-3 upon reaction with 
Bu,,N+‘~F-/Bu,N+OH~, supports this view. The 
identity of 18F-3 was confirmed by TLC and HPLC 
comparison with authentic 3, synthesized by the 
Merck method. This anomalous radiochemical reac- 
tion is also remarkable in that it gives exceedingly 
high “F incorporation and a product of high radio- 
chemical purity (> 99%). Isolated yields are as high 
as 68% (93% corrected for decay); virtually the only 
other fluorine- 18 species is unreacted [‘” Flfluoride ion 
which can be removed by a variety of methods, 
including liquid-liquid extraction or bonded-phase 
chromatography. Chemical impurities are few, but 
are apparently different depending on the choice of 
starting material. Trace chemical impurities such as 1 
are removed from the final product by HPLC 
purification. With further optimization studies, it will 
likely be possible to eliminate the tracer chemical 
impurities by a simple Sep-Pak procedure. When 
aqueous HCl is used in the radiochemical workup of 
the [‘8F]fluoride reaction with the cyclic sulfamate 9, 
the chloromethyl analog 10 has been observed to 
form, seemingly through Cl- attack on the cyclic 
sulfamate 9. Use of the hydroxytriflamide 8 gives no 
chloromethyl contaminant on aqueous HCl workup. 
Compound 10 was synthesized separately by reaction 
of 1 with thionyl chloride. 
Table 2. MK-801 derivatives: binding affinities 
Compound K, f SD (nM)* 
(+)MK-80 1 22 _+ 2 
(+)MK-801 19+ II 
(f )N-Methyl-MK-801 I58 222 
(*)I-Iodo-MK-801 790* II0 
(k)3-Bromo-MK-801 0.8 + 0.3 
(i)l3-Fluoromethyl-MK-801 79 * 22 
*N=3. 
Binding and log P studies 
Substitution of iodine in the l-position decreases 
the binding affinity IO-fold (Table 2). Although un- 
labeled (+)3-iodo-MK-801 was not available for 
competitive binding studies, it is noteworthy that 
(+)3-bromo-MK-801, which is likely to mimic the 
3-iodo isomer, has a loo-fold greater affinity than 
(+)MK-801 and a lOOO-fold greater affinity than 
(f)l-iodo-MK-801 for the TCP binding site. This 
high sensitivity to the halogen substitution pattern 
underscores the need to do further SAR studies. 
Results of binding studies with (k)N-methyl-MK- 
801 and ( + ) 13-fluoromethyl-MK-801, derivatives 
amenable to labeling with “C and 18F, respectively, 
show that N-methylation slightly lowers binding 
affinity, whereas fluoromethylation of the bridgehead 
methyl group has no observable effect on binding. 
The radiotracers synthesized in this study are racemic 
ligands; however the (+) enantiomers are expected to 
show enhanced binding (See Table 2). 
It has become clear in recent years that a 
“window” of lipophihcity exists for optimum passage 
of a drug or tracer through the blood-brain barrier 
(Hansch et al., 1987). This optimum log P is 2 _t 0.5. 
A log P value of 2.1 & 0.1 was obtained for free base 
Labeling of MK-801 with “‘1 and 18F 1225 
MK-801. The addition of an iodine atom to MK-801 direct iodination of aromatic compounds. J. Chem. Sot. 
will likely raise the log P to approximately 3; incorpo- 3694. 
ration of the fluoromethyl group should have a lesser Deutsch S. I. and Morihisa J. M. (1988) Glutamatergic 
effect (Leo et al., 1971). In any case, CNS penetration 
abnormalities in Alzheimer’s Disease and a rationale for 
should not be an obstacle for the tracer MK-801 
clinical trials with L-glutamate. Clin. Neuropharm. 11, 18. 
Frey K. A., Wieland D. M., Brown L. E., Rogers W. L. and 
derivatives synthesized in this study. Agranoff B. W. (1981) Development of a tomographic 
myelin stain. Ann. Neural. 10, 214. 
Conclusions 
Gildersleeve D. L.. Lin T-Y.. Wieland D. M.. Ciliax B. J. 
and Young A. B. (1988) Synthesis of high specific activity 
MK-801, a drug that binds with high affinity and [‘251]PK11~95, a potential agent for SPEdT imaging df 
selectivity to the glutamate-linked cation channel in 
the peripheral benzodiazepine receptor. Nucl. Med. Biol. _ _ 
mammalian brain, can be radiolabeled as a tracer for 
(In press) (MS 169). 
possible use in both SPECT and PET imaging tech- 
Greenamyre J. T., Penney J. B., Young A. B., D’Amato 
C. J., Hicks S. P. and Shoulson I. (1985) Alternations in 
niques. This preliminary work lays the groundwork L-glutamate binding in Alzheimer’s and Huntington’s 
for a more detailed study of radiolabeled MK-801 Disease. Science 227, 1496. 
derivatives as possible NMDA receptor-based imag- 
Hansch C., Bjorkroth J. P. and Leo A. (1987) Hydro- 
ing agents. It clearly demonstates that foreign iso- 
phobicity and central nervous system agents: On the 
topes, both large (‘251) and small (‘*F), can be 
principle of minimal hydrophobicity in drug design. 
J. Pharm. Sri. 76, 663. 
incorporated into the MK-801 framework by con- Honey C. R., Miljkovic 2. and MacDonald J. F. (1985) 
venient, high-yield methods without compromising 
Ketamine and phencyclidine cause a voltage-dependent 
the binding affinity. A number of reactions involving 
block of responses of L-aspartic acid. Neurosci. Left. 61, 
135. 
the MK-801 ring structure are unusual. One of these, Kemp J. A., Foster A. C., Gill R. and Woodruff G. N. 
the in situ formation of a cyclic sulfamate, provides (1987) MK-801, NMDA receptors and ischaemia-induced 
an unexpectedly easy method for fluorine-18 label- neurodegeneration. TIPS 8, 414. 
ing MK-801. In uivo evaluation of (f)3-[‘*‘I]iodo- 
Leo A., Hansch C. and Elkins D. (1971). Partition 
MK-801 and ( +)13-[‘8F]fluoromethyl-MK-801 is in 
coefficients and their uses. Chem. Rev. 71, 525. 
Lvle R. A.. Magi11 C. A. and Pitzenberger S. M. (1987) 
progress. -Fluoride-induced formation and ring opening of ‘cyclic 
sulfamates from hydroxytriflamides. Synthetic and 
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